Loading...
Loading...
Among the 2 tracked institutional investors we monitor, GLMD (GALMED PHARMACEUTICALS LTD) is held with a combined value of $71.95K across 118,342 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $48.31K. TWO SIGMA ADVISERS, LP opened a new position in the most recent quarter. 1 fund increased its holdings.
Total Institutional Value
$71.95K
Total Shares Held
118,342
Institutional Holders
2
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $48.31K | 0.00% | +663.1% |
| 2 | TWO SIGMA ADVISERS, LP | $23.63K | 0.00% | New |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of GLMD with a position worth $48.31K, representing 0.00% of their portfolio. In total, 2 institutional investors hold GLMD with a combined value of $71.95K.
In the most recent quarter, 1 fund opened a new position in GLMD. Additionally, 1 increased their holdings.
Institutional investors hold $71.95K worth of GLMD stock across 2 positions. The largest institutional holder is CITADEL ADVISORS LLC with $48.31K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GLMD, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GLMD positions.
Last Close
$4.30
2026-08-21
YTD
-34.6%
6% of 52-week range